Home > Flashcards > Print Preview

The flashcards below were created by user victimsofadown on FreezingBlue Flashcards. What would you like to do?

  1. What are the two processes involved in the preparation of peptide antigens in a cleft on MHC molecules w/ brief description?
    • Antigen processing: generation of peptides from native proteins
    • Antigen presentation: display of the peptide by the MHC at the cell surface
  2. What are the three types of pathogens (by area found) w/ examples
    • Cytosolic: viruses, L. monocytogenes
    • Intravesicular: M. tuberculosis, Leishmania (replicate inside macrophages)
    • Extracellular: toxins and various pathogens (internalized before being digested)
  3. Type of pathogen (by area) / presented on / recognized by.
    • Cytosolic pathogen: MHC I, CD8 Tcyto
    • Intravesicular/Extracellular: MHC II, CD4 Thelper
    • cross presentation: peptides are presented on the the "unexpected" MHC molecule
  4. How do Dendritic cells differ from macrophages and B cells re: APC?
    • Dendritic cells: activate both CD8 and CD4
    • Macrophages: activate CD4 cells that act back on that macrophage
    • B cells: activate CD4 cells that will be helper cells for antigen's antibody production
  5. Overview of MHC I pathway w/ all important details
    • Proteasome breaks down virus in cytoplasm
    • Peptide fragments are transferred to lumen of ER via TAP complex
    • MHC class I are present in the ER until they bind peptides
    • Peptide editing: various peptides are "tried" until a peptide is stably bound
    • *note- some DRiPs will be stable, and will be bound
    • *note- most peptides will not bind, and will be transported back into the cytosol
    • Proper binding results in a stable conformation, and the transportation of MHC I + peptide complex to membrane
  6. Describe constitutive proteasome structure and function.
    • Composed of one 20S catalytic core and two 19S regulatory caps
    • Ubiquitin modification of protein is detected by the 19S cap
    • Protein is introduced to 20S catalytic core where degradation occurs
    • Functions in normal protein turnover
  7. Describe immunoproteasome structure and function
    • The immunoproteasome is present in cells stimulated by IFN γ which...
    • Produces peptide fragments which have preferred anchor residues for MHC I and for TAP transport
    • Causes 20S proteasomes to bind to immunoproteasome regulator caps
    • Upregulation of ERAPP allows further trimming of peptides
  8. What are immunoevasins? Describe the potential mechanisms
    • proteins released by viruses that prevent the appearance of peptide:MHC I complexes on the surface of infected cells in an attempt to evade CD8 Tcyto
    • Target TAP transporter
    • Inhibit peptide loading by MHC I in ER
    • Ubiquinate immature MHC I complex (tag for destruction)
  9. What are the types of antigens processed and presented by MHC II?
    • Extracellular pathogens/proteins: internalized to endocytic vesicles
    • Intracellular pathogens: replicate inside vesicles in macrophages
    • Antigens that bind to sIg on B cells: internalized by receptor-mediated endocytosis
  10. Overview of MHC II pathway with all important details
    • Antigens are contained within endosomes
    • Endosomes become increasingly acidic (via vacuolar ATPase) activating acid proteases that degrade the antigens into peptides
    • Invariant chains prevent peptides from binding to the MHC II in the ER and deliver the CLIP:MHC II complex to the low-pH endosome
    • CLIP: a peptide that "blocks" other peptides from binding MHC II
    • The two endosomes are fused
    • HLA-DM releases CLIP from MHC II, and allows peptide editing to occur
  11. Give the two examples of antigen cross-presentation.
    • Non-infected dendritic cells present Ag from external source on MHC I to activate CD8 Tcyto (otherwise how to Tcyto target these pathogens?)
    • Loading of cytosol-derived proteins onto MHC II molecules to activate CD4 Thelper (otherwise how could the B cells become activated?)
    • *most likely due to autophagy
  12. What are the two properties of MHC that make it difficult for pathogens to evade?
    • polygenic: contains several different genes in every individual, which creates a range of peptide specificities
    • polymorphic: each person has variant alleles within the population. HIGHLY polymorphic
    • *note- evading MHC presentation would be detrimental to the host and incredibly beneficial to the pathogen
  13. Describe the polygeny and polymorphism of MHC molecules in detail with proper terms.
    • polygeny
    • MHC genes are called HLA (Human Leukocyte Antigen) genes
    • There are 3 MHC I α genes (HLA-A/B/C)
    • There are 3 pairs of MHC II α:β genes (HLA-DP, DQ, DR)
    • *note- the HLA-DR cluster contains a few extra β chains, which increases variability
    • *note- most polymorphism is restricted to the peptide-binding cleft, altering anchor residues for a given MHC molecule
    • polymorphic
    • There are over 800 different alleles for HLA genes in the population, and most will be heterozygous for these genes
  14. Describe the interplay between MHC and T cells  and the medical issues that can be caused
    • MHC Restriction: another name for dual specificity
    • Before leaving the Thymus T cells must undergo positive selection for your MHC molecules
    • Alloreactive T cells: recognize and react to non-self MHC molecules (any nucleated cell has MHC I).
    • Alloreactivity common in transplantation.
  15. How do superantigens work?
    • Superantigens bind (intact) to MHC II molecules on the surface of a cell and the Vβ region of the TCR
    • In this way they stimulate large number of T cells...
    • releasing cytokines (IFN γ) and causing septic shock
    • Preventing T cells from specifically binding to antigens
  16. What are the three protein kinases in humans?
    • Tyrosine protein kinases (most common for BCR/TCR)
    • Serine protein kinases
    • Threonine protein kinases
    • (all have -OH group that is phosphorylated)
  17. What are the two "types" (re: association with receptor) of kinases, and how do they function?
    • Receptor kinases: (covalent) one protein has receptor and kinase
    • Upon ligand binding the receptor/kinase protein dimerizes.autophosphorylates
    • Non-receptor kinases: (noncovalent) two proteins
    • 1. The kinase and receptor are noncovalently associated at the membrane and dimerize/autophosphorylate after ligand binding
    • 2. The kinase is associated with a membrane protein unassociated with the receptor.  The two are only brought together after ligand binds to the receptor by co-receptors
    • *note- this is most important to lymphocyte receptors
  18. What enzyme does the opposite job of a kinase?
    protein phosphatases
  19. What are the important domains involved in the creation of multi-protein receptor complexes
    • SH2: binds a phosphotyrosine (most relevant to the Tyr kinase pathways we've been discussing)
    • eg pYXXZ (phosph.Tyr, any, any, hydrophobic)
    • Different SH2 domains prefer different AA combinations
    • SH3: recognizes proline
    • PH: recognize PIP3
  20. Scaffolds vs. Adaptors
    • Both are used by Tyr Kinases to assemble multi-protein signalling complexes
    • Scaffolds: bring multiple proteins to receptor
    • phosphorylated by the kinase in multiple places
    • Can recruit many different proteins on these sites
    • Adaptors: link two molecules
    • are bound to a different signalling proteins in cytoplasm
    • Bind to phosphorylated kinase, linking the signalling proteins to the receptor
  21. What are small G proteins? Example? (not HOW they work)
    • AKA small GTPases
    • Distinct from large heterotrimeric G proteins
    • Act as molecular switches in pathways leading from Tyr kinase-associated receptors (act downstream)
    • Ras, Rac, Rho, and Cdc42 are examples
  22. How do small G proteins work?  What enzymes regulate them?
    • GDP-bound form is inactive, GTP-bound form is active
    • Guanine-nucleotide exchange factors (GEFs): induce conformational change in small GTPase to catalyze exchange of GDP for GTP (activation)
    • GTPase-activating proteins (GAPs): accelerate the intrinsic hydrolysis of GTP->GDP (deactivation)
    • *note- each G protein has its own specific GEFs and GAPs to retain pathway specificity
  23. What are the two pathways for intracellular signalling proteins to be recruited to the plasma membrane? w/ description
    • Tyr protein kinase pathway: Tyr phosphorylation of the receptor or associated scaffold followed by recruitment of SH2-domain containing signalling proteins or adaptors
    • Subsequent recruitment of GEFs can activates associated small GTPases that can act on downstream targets
    • Phosphatidylinositol kinase pathway: local phophatidylinositol phosphorylation recruits signalling proteins (PIP2 -> DAG/IP3) (PIP2 -> PIP3)
    • PI3-kinase is most important, converting membrane PIP2 to membrane PIP3 which is recognized by proteins with a PH domain
  24. What are the two general mechanisms for signal termination?
    • Dephosphorylation by phosphatases
    • Degradation of signaling proteins by ubiquitin-proteasome system
  25. Describe the ubiquitination of proteins involved in signalling and the potential outcomes
    • Dephosphorylation by phosphatases
    • Degradation of signaling proteins by ubiquitin-proteasome system
    • *note- polyubiquitination at Lys 48 causes degredation, but at Lys 63 activates some signalling pathways
  26. What is the name for the molecules that amplify the signal within a cell? Give common examples generated in Tyr kinase pathways
    • Second messengers
    • Ca2+ ions and a variety of membrane lipids/soluble derivatives
  27. What does the functional ("true") TCR look like w/ general functions
    • [TCRα:β + CD3 (γ+δ+ε) + ζ] + [CD4/CD8]
    • α:β: bind the antigen
    • CD3 & ζ: have ITAMs for phosphorylation (signal function)
    • The entire complex is needed for stability and transport to the membrane (electrostatic interactions)
    • *note- each ITAM has two Tyr residues that become phosphorylated when receptor binds ligand, allowing SH2 domain recruitment
  28. What does the functional ("true") BCR look like w/ general functions
    • sIg + [Igα +Igβ]
    • sIg: bind the antigen
    • Igα and Igβ: have ITAMs for phosphorylaton (signal function)
    • The entire complex is needed for stability and transport to the membrane (hydrophillic interactions)
  29. How are co-receptors involved in the signaling pathway (TCR)?
    • CD4 and CD8 help in two ways
    • 1. LCK is noncovalently bound to the coreceptor
    • During ligand binding co-receptors are brought close, and LCK phosphorylates the ITAMs on the TCR
    • 2. Co-receptors stabilize the interaction between TCR and MHC:peptide complex, giving time for signal to be generated
  30. Give the TCR signalling overview with all important interactions and outcomes
    • Co-stimulatory molecules are brought to TCR during ligand binding
    • LCK on co-stimulatory molecules phosphorylats the ITAMs on TCR
    • ZAP70 recognizes P'd ITAMs via SH2 domain and P's other molecules (scaffolds)
    • PLC-γ is bound to membrane by PIP3 and scaffolds
    • *note-PIP3 kinase (req for PIP3) is activated by the costimulatory (CD28 to CD80/86) signal
    • PIP3 also recruits Itk to phosphorylate PLC-γ
    • PLC-γ acts as enzyme on PIP2 to create membrane-bound DAG and cytoplasmic IP3
    • DAG leads to Ras activation and PKC-θ
    • IP3 leads to Ca2+ entry
  31. Describe each of the potential signalling activation pathways of TCRs (what PLC-γ enacts) with some detail
    • Ca2+: Ca2+ leaves ER, and binds to calmodulin, which binds to calcineurin, which dephosphorylates NFATs
    • The now activated NFATs move to nucleus and bind promotor elements
    • Ras: Ras activated by GEF, tiggers 3-kinase relay that results in activation of transcription factor AP-1
    • PKC-θ: recruited to membrane and then results in NFκB activation by (P by PKC-θ causes removal of inhibitor from NFκB)
    • *note- NFAT, AP-1, and NFκB all bind to the promoter region of IL-2, and all are required to stimulate transcription
  32. compare/contrast BCR and TCR signalling pathways (specifically the homologous enzymes)
    • TCR signalling: LcK (brought by CD4/CD8) P's the ITAMs (CD3+ζ) which are recognized by ZAP-70 to initiate signalling
    • Coreceptor CD4/CD8 brings LcK
    • BCR signalling: Fyn, Blk, Lyn (associated with Igα and β) P's the ITAMs (Igα and β) upon ligand binding/receptor clustering which are recognized by Syk to initiate signalling
    • Coreceptor CD19, 21, 81 complex brings PI3Kinase, but PI3 kinase is not involved in activation (no "2 signal" requirement)
  33. What are the stages of B cell development w/ names and overview of what's happening (image recap)
    • Stem cell: receives stromal cell signalling
    • Early pro-B cell: H-Chain D-J rearrangement
    • Late pro-B cell: H-Chain V-DJ rearrangmement
    • Large pre-B cell: Test H-Chain w/ surrogate L-chain (VpreB & λ5) + Igα, Igβ ("pre-B receptor")
    • *Allelic exclusion
    • Small pre-B cell: L-Chain V-J rearrangement
    • *Allelic exclusion AND isotypic exclusion
    • *30-60 cells with same H-chain, different L-chain result
    • Immature B cell: negative selection, IgM expressed on surface
    • Mature B cell: IgD and IgM made from alternatively spliced H-chain transcripts
  34. Different between progenitor cells and precursor cells
    • Progenitor cells: initiate rearrangement of heavy chain. 
    • Cells become precursor cells
    • Precursor cells: initiate rearrangement of light chain.
    • Cells become immature cells
  35. What are stromal cells? What is their function?
    • specialized non-lymphoid CT in intimate contact w/ developing lymphocytes
    • 1. form specific adhesive contacts with lymphocytes (provides signalling within lymphocytes)
    • 2. provide cytokines and chemokines which control lymphocyte differentiation and proliferation
  36. How do pre-B cell receptors get tested for successful rearrangement?  What are the results?
    • 1. Incorporating the rearranged heavy chain into a receptor on the cell surface w/ surrogate light chain (VpreB and λ5)
    • 2. Assembly of invariant proteins Igα and β on the cell surface
    • Successfully formed Pre-B cell receptors dimerize and generate signals to halt further rearrangement (allelic exclusion) and initiates transition to large Pre-B cell
  37. What are the three ways that allelic exclusion is promoted by the pre-B receptor
    • 1.Reduces V(D)J recombinase activity (lower RAG-1 and RAG-2 expression)
    • 2. Reduces levels of RAG-2 by targeting remaining for degredation
    • 3. Reduces access access of the H-chain locus to the recombinase machinery
  38. Why does light chain rearrangement in pre-B cells have a higher chance of generating an intact light chain? (than H-chain)
    • 1. If VJ rearrangement of κ-chain genes on one chromosome fails, repeated rearrangements of unused V and J will occur until rearrangement is productive
    • 2. If this fails then VJ rearrangement of κ genes is tried on the second chromosome
    • 3. If this fails then λ rearrangement may succeed (also has second chromosome to try)
    • *note-same is true for α segments over β segments
  39. Allelic vs isotypic exclusion.  Descriptions and when they occur
    • Allelic exclusion: a successful rearrangement silences the unsuccessful chromosome
    • B cells- Large pre-B (after H-chain) and Small pre-B (afer L-chain)
    • T cells- β and delayed α
    • Isotypic exclusion: a successful rearrangment of a light-chain isotype (κ or λ) prevents the other from being expressed
    • B cells- Small pre-B (after L-chain)
    • T cells- none
  40. Describe the differences in autoreactivity testing between B cells and T cells
    • B cells: immature B cell is tested for autoreactivity in the bone marrow
    • Negative selection dictates that B cells will be tolerant of self antigents
    • T cells: immature T cell is tested for autoreactivity in the Thymus
    • Negative selection dictates that the T cells will be tolerant of self antigens
    • Positive selection dictates that the T cells will recognize self MHC molecules
  41. What are the 5 possible fates of immature B cells in response to self-antigens.
    • Normal maturation: no strong reactivity to self antigen
    • Clonal deletion: cell death by apoptosis (after attempt at editing)
    • Receptor editing: the successful production of a new receptor
    • Anergy: perminantly unresponsive, will later die
    • Immunological ignorance: no response to self-antigen test, but will react if presented with the self-antigen (eg crystallin only in lens)
  42. Similarities and Differences between B cell and T cell development
    • Similarities: orderly and stepwise rearrangment of antigen-receptor genes with testing
    • selection is dependent on interaction with other cells (stromal or thymal)
    • Differences: T cell has two selection processes
    • T cell has two distinct lineages (γ:δ and α:β) which express different ag-receptor genes
  43. What are the stages of α:β T cell development w/ names and overview of what's happening (image recap)
    • Stem cell: receives thymic stromal cell signalling
    • DN1: expresses no marker proteins
    • DN2: β chain VJD rearrangement (analogous to H-chain)
    • DN3: Pre-T receptor is tested using surrogate α chain
    • *allelic exclusion
    • DN4: cell proliferation
    • Large DP: α chain VJ rearrangement occurs
    • *expresses both CD4 and CD8
    • Small DP: 2 TCRs are present on the surface (invariant pTα and CD3 molecules make up "pre T cell receptor")
    • both TCRs undergo + and - selection
    • *allelic exclusion occurs
    • SP: a single TCR is now presented on the surface along with EITHER CD4 (helper) or CD8 (killer)
    • *only cell in medulla
    • Mature T cell:
  44. Describe the cellular architecture of the thymus and what stages of T cells appear where.  How does this factor into selection?
    • Cortex: composed of epithelia that express both MHC I and II (crucial role in positive selection)
    • contains only immature thymocytes and scattered macrophages
    • Medulla: contains only mature single-positive thymocytes with dendritic cells and macrophages
    • Site of negative selection
    • dendritic cells and macrophages express co-stimulatory molecules not present in cortex
  45. Describe the positive and negative selection of T cells
    • DP cells will die in 3-4 days unless they undergo selection
    • Positive selection: ~30% of thymocytes will be able to recognize self-peptide:self MHC
    • takes place in cortex
    • determines if cell will be CD4 or CD8
    • Negative selection: Those who recognize the complex too strongly undergo apoptosis (~2% survive at the end)

Card Set Information

2013-11-13 16:30:11

Show Answers:

What would you like to do?

Home > Flashcards > Print Preview